We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of WINT yet.

WINT Hedge Fund Activity: Q4 2017 in Review

0 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2017, worth a combined $0 — down 100% from $41K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of WINT and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Panagora Asset Management, exiting entirely with an estimated $37K sold.

  • 0 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2017, down from 3 in Q3 2017.
  • Funds reported $0 of Windtree Therapeutics Inc stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Windtree Therapeutics Inc positions in Q4 2017 and 3 closed out, a net change of -3 holders.
  • The largest Windtree Therapeutics Inc seller in Q4 2017 was Panagora Asset Management, an estimated $37K sold.

Based on aggregated 13F filings for Q4 2017.